Respiratory groups slam Big Tobacco plan to pay pharmacies for vaping promotion
Respiratory professional groups and doctor organisations have slammed reports that Big Tobacco will enter into commercial agreements with community pharmacies to promote the sale of nicotine e-cigarettes, ostensibly for smoking cessation. The multinational tobacco company Philip Morris is reportedly offering cash incentives to Australian pharmacists in return for spruiking one of...
Update & debate — the changing face of COPD
Join your colleagues for dinner in Melbourne or watch online as a team of expert respiratory physicians discusses best practice and tackles a hot topic in COPD management. Hosted by Professor Christine McDonald Director, Dept of Respiratory & Sleep Medicine; Medical Director, Institute for Breathing & Sleep, Austin...
CFTR modulator trial in infants paves the way for earlier access: Australian expert
A trial in children under two years of age with cystic fibrosis will pave the way to earlier access to CFTR modulation and maybe to modifying the course of disease for up to 50% of very young children with CF, an Australian expert says. Results from...
Dyspnoea’s high morbidity and mortality burden in ambulance callouts
Patients with dyspnoea transported by ambulance to hospital have a high morbidity and mortality from respiratory diseases , a Victorian study shows. One in every seven Australian patients who call for an ambulance are exhibiting breathlessness when crews arrive, the analysis...
Patients with dyspnoea transported by ambulance to hospital have a high morbidity and mortality from respiratory diseases , a Victorian...
Age 40 the watershed for addressing asthma exacerbation burden
Asthma exacerbations are associated with faster lung function decline, particularly in younger patients, the largest study of its kind confirms. The findings highlight the “potential value” of addressing exacerbation burden when patients are still in the growth...
Asthma exacerbations are associated with faster lung function decline, particularly in younger patients, the largest study of its...
PAL phenotype a treatable trait even in mild asthma: ATLANTIS
Increasing treatment intensity should be considered in patients with milder asthma and the persistent airflow limitation (PAL) phenotype, a new analysis of the landmark ATLANTIS study suggests. The PAL phenotype is present in people living with asthma across the spectrum of...
Increasing treatment intensity should be considered in patients with milder asthma and the persistent airflow limitation (PAL) phenotype, a new...